Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells.

Biochemical and biophysical research communications - 3 Sept 2026

Fan Xiaofang, Zhao Hengping, Wu Bin, Lv Yichen, Chen Wei, Chen Qi, Hu Lingyu, Yu Shenjie, Wang Jiale, He Yahui, Yu Jiaqi

Abstract excerpt

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor prognosis. DDB1 and CUL4 associated factor 13 (DCAF13) has been implicated in tumor progression, but its clinical relevance and biological function in PDAC remain unclear. METHODS: Public databases (GEPIA2 and Kaplan-Meier Plotter) were used to analyze DCAF13 expression and its prognostic value in PDAC. Tumor and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Cell Movement

Share to Disease Progression

Share to Gene Expression Regulation, Neoplastic

Share to Pancreatic Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 42361739
DOI: 10.1016/j.bbrc.2026.154207

Genes

DCAF13
TP53
BAX
C7
DDB1
FAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells.PMID 42361739Read ↗

Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinomaSemantic proximity Read ↗

The overexpression and prognostic role of DCAF13 in hepatocellular carcinomaSemantic proximity Read ↗

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Clinical Significance and Prognostic Value of the Expression of Fibronectin Type III Domain Containing 3B in Pancreatic CarcinomaSemantic proximity Read ↗

Discovering a specialized programmed-cell death patterns for prognostic model of pancreatic ductal carcinoma via machine learningSemantic proximity Read ↗

Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.Semantic proximity Read ↗

Expression of p53 and C-Myc in pancreatic ductal adenocarcinoma and their association with clinicopathological, molecular, prognostic and survival variables in patients of Fundación Santa Fe de Bogotá University Hospital, between 2009-2022.Semantic proximity Read ↗

FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expressionSemantic proximity Read ↗

DDX31: A Novel Functional Oncogene Promotes Migration and Proliferation of Pancreatic CancerSemantic proximity Read ↗

Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethalitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.